نتائج البحث

1

Impact of comorbidities and body mass index on the outcome of polycythemia vera patients

المساهمون: Benevolo G., Elli E.M., Bartoletti D., Latagliata R., Tiribelli M., Heidel F.H., Cavazzini F., Bonifacio M., Crugnola M., Binotto G., D'Addio A., Tieghi A., Bergamaschi M., Caocci G., Polverelli N., Bossi E., Auteri G., Carmosino I., Catani L., Cuneo A., Krampera M., Lanza F., Lemoli R.M., Vianelli N., Breccia M., Palumbo G.A., Cavo M., Palandri F.

المصدر: Hematological Oncology. 39:409-418

مصطلحات موضوعية: Male, Cancer Research, Comorbidity, Overweight, Primary Myelofibrosi, 0302 clinical medicine, Retrospective Studie, Risk Factors, body mass index, cancer, Charlson comorbidity index, outcome, polycythemia vera, thrombotic risk, 80 and over, Cumulative incidence, Aged, 80 and over, Incidence, Incidence (epidemiology), Hazard ratio, Hematology, General Medicine, Middle Aged, Oncology, 030220 oncology & carcinogenesis, Thrombosi, Female, Underweight, medicine.symptom, Human, Adult, medicine.medical_specialty, NO, Follow-Up Studie, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, Retrospective Studies, business.industry, Risk Factor, Thrombosis, Retrospective cohort study, medicine.disease, Follow-Up Studies, Polycythemia Vera, Primary Myelofibrosis, Body Mass Index, Body Mass Index, Cancer, Charlson Comorbidity Index, Outcome, Polycythemia Vera, Thrombotic risk, business, Body mass index, 030215 immunology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3939263de47b0f932025c0ddc18dfcTest
https://doi.org/10.1002/hon.2843Test

2

Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy

المساهمون: Chari A., Munder M., Weisel K., Jenner M., Bygrave C., Petrucci M.T., Boccadoro M., Cavo M., van de Donk N.W.C.J., Turgut M., Demirkan F., Karadogan I., Libby E., Kleiman R., Kuppens S., Bandekar R., Neff T., Heuck C., Qi M., Clemens P.L., Goldschmidt H.

المصدر: Advances in Therapy

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ce97228f47369191000ad6884b6823Test
https://doi.org/10.1007/s12325-020-01601-wTest

3

Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement

المؤلفون: Jacopo Nanni, Cristina Papayannidis, Antonio Curti, Francesco Barbato, Stefania Paolini, Sarah Parisi, Michele Cavo, Francesca Bonifazi, Mario Arpinati, Gianluca Cristiano, Giovanni Marconi, Chiara Sartor

المساهمون: Cristiano G., Nanni J., Sartor C., Parisi S., Marconi G., Barbato F., Arpinati M., Bonifazi F., Curti A., Cavo M., Paolini S., Papayannidis C.

المصدر: Acta Haematologica. 144:688-692

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Fusion Proteins, bcr-abl, Protein Kinase Inhibitor, Chromosomal translocation, Hematopoietic stem cell transplantation, Philadelphia chromosome, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, chemistry.chemical_compound, Bone Marrow, Positron Emission Tomography Computed Tomography, hemic and lymphatic diseases, Internal medicine, Medicine, Imidazole, Chemotherapy, Acute leukemia, business.industry, Ponatinib, Myeloid leukemia, Hematology, General Medicine, Middle Aged, medicine.disease, Treatment Outcome, chemistry, Nelarabine, Pyridazine, business, T-cell acute lymphoblastic leukemia, Human, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9817e9a4d94ebcf35ffc08bcc79cc94eTest
https://doi.org/10.1159/000516003Test

4

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

المؤلفون: Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino

المساهمون: Tacchetti P., Pantani L., Patriarca F., Petrucci M.T., Zamagni E., Dozza L., Galli M., Di Raimondo F., Crippa C., Boccadoro M., Barbato S., Tosi P., Narni F., Montefusco V., Testoni N., Spadano A., Terragna C., Pescosta N., Marzocchi G., Cellini C., Galieni P., Ronconi S., Gobbi M., Catalano L., Lazzaro A., De Sabbata G., Cangialosi C., Ciambelli F., Musto P., Elice F., Cavo M., Fanin R., Foa' R., Rambaldi A., Rossi G., Leoni P., Corradini P., Torelli G., Fioritoni G., Cortelazzo S., Lambertenghi Deliliers G., La Nasa G., Zaccaria A., De Fabritiis P., Cascavilla N., Bosi A., Semenzato G., Gugliotta L., Gherlinzoni F., Angelucci E., Martelli M.F., Petti M.C., Leone G., Carella A.M., Ciceri F., Santoro A., Ferrara F., Nobile F., D'Arco A.M., Levis A., Guardigni L., Gallamini A., Fattori P.P., Morandi S., Amadori D., Rotoli B., Mirto S., Paladini G., Mozzana R., Pinotti G., Rodeghiero F., Cantore N., Pavone V., Pogliani E.M., Liberati A.M., Majolino I., Amadori S., Lauria F., Aglietta M., Quarta G., Storti S., Morabito F., Capalbo S.F., Gianni A.M., Mettivier V., Rizzoli V., Bernasconi C., Visani G., Pizzuti M., La Verde G., Avvisati G., Longinotti M., Gallo E., Dammacco F., Russo D., Bacigalupo A., Musolino C.

المصدر: The Lancet Haematology. 7:e861-e873

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Adolescent, Phases of clinical research, Transplantation, Autologous, Dexamethasone, Bortezomib, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, GIMEMA-MMY-3006 trial, bortezomib, thalidomide, dexamethasone, VTD, double autologous haematopoietic stem-cell transplantation, multiple myeloma, Multiple myeloma, Aged, Intention-to-treat analysis, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, medicine.disease, Thalidomide, Transplantation, Regimen, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, Follow-Up Studies, 030215 immunology, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d247cf6931cb796a2568e2552250ca02Test
https://doi.org/10.1016/s2352-3026Test(20)30323-9

5

Expanding CD38-targeting triplets for relapsed or refractory multiple myeloma

المؤلفون: Paola Tacchetti, Elena Zamagni, Michele Cavo

المساهمون: Cavo M., Tacchetti P., Zamagni E.

المصدر: The Lancet. 397:2311-2313

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, MEDLINE, Refractory Multiple Myeloma, General Medicine, CD38, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Text mining, Internal medicine, medicine, Humans, Multiple Myeloma, business, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa56253f62a2ff2119fb6ab61fbb3d1Test
https://doi.org/10.1016/s0140-6736Test(21)00729-7

6

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis

المؤلفون: Michele Cavo, Vania Hungria, Bart Heeg, Andrea Garcia, Meletios A. Dimopoulos, Mariana Fernandez, Deborah M. Martínez-Baños, Maria-Victoria Mateos, Jianming He, Gerardo Machnicki, Annette Lam

المساهمون: Hungria V., Martinez-Banos D.M., Mateos M.-V., Dimopoulos M.A., Cavo M., Heeg B., Garcia A., Lam A., Machnicki G., He J., Fernandez M.

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Melphalan, 030213 general clinical medicine, medicine.medical_specialty, Population, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Multiple myeloma, Daratumumab, Propensity score matching, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Pharmacology (medical), Propensity Score, education, Aged, Retrospective Studies, Original Research, education.field_of_study, business.industry, Antibodies, Monoclonal, Standard of Care, General Medicine, Middle Aged, medicine.disease, Progression-Free Survival, Confidence interval, Hemato-Oncology Latin America, Latin America, ALYCONE, 030220 oncology & carcinogenesis, Cohort, Prednisone, Indirect treatment comparison, Female, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d30dae92d709ef6526889f33c6e8d32bTest
https://doi.org/10.1007/s12325-020-01521-9Test

7

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

المساهمون: Martinelli, Giovanni, Papayannidis, Cristina, Piciocchi, Alfonso, Robustelli, Valentina, Soverini, Simona, Terragna, Carolina, Marconi, Giovanni, Lemoli, Roberto Massimo, Guolo, Fabio, Fornaro, Antonella, Lunghi, Monia, de Fabritiis, Paolo, Candoni, Anna, Selleri, Carmine, Simonetti, Federico, Bocchia, Monica, Vitale, Antonella, Frison, Luca, Tedeschi, Alessandra, Cuneo, Antonio, Bonifacio, Massimiliano, Martelli, Maria Paola, D'Ardia, Stefano, Trappolini, Silvia, Tosi, Patrizia, Galieni, Piero, Fabbiano, Francesco, Abbenante, Maria Chiara, Granier, Muriel, Zhu, Zhaoyin, Wang, Mingyue, Sartor, Chiara, Paolini, Stefania, Cavo, Michele, Foà, Robin, Fazi, Paola, Vignetti, Marco, Baccarani, Michele

مصطلحات موضوعية: medicine.medical_specialty, Population, Gastroenterology, Disease-Free Survival, chemistry.chemical_compound, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Tyrosine kinase inhibitors, Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), GIMEMA LAL 1811, medicine, Clinical endpoint, Humans, Philadelphia Chromosome, Prospective Studies, education, Adverse effect, Aged, education.field_of_study, biology, business.industry, Ponatinib, Imidazoles, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Settore MED/15, Rash, Pyridazines, Transplantation, chemistry, Alanine transaminase, biology.protein, medicine.symptom, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532a7ef6c6f327838c21185db5ce9234Test
http://hdl.handle.net/11567/1078678Test

8

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

المؤلفون: Francesco Merli, Carlo Visco, Annarita Conconi, Daniele Vallisa, Elettra Ortu La Barbera, Sara Galimberti, Roberto Mina, Marianna Sassone, Anna Guidetti, Adriano Venditti, Alessandro Corso, Francesco Marchesi, Pellegrino Musto, Agostino Tafuri, Valentina Bonuomo, Filippo Gherlinzoni, Francesco Lanza, Monia Marchetti, Safaa M. Ramadan, Marco Salvini, Massimo Massaia, Elisa Coviello, Alessandro Busca, Luigi Petrucci, Daniele Armiento, Mauro Turrini, Alessandra Romano, Chiara Cattaneo, Francesco Passamonti, Matteo G. Della Porta, Anna Candoni, Luigi Rigacci, Luca Arcaini, Livio Trentin, Valeria Cardinali, Maria Chiara Tisi, Carmine Selleri, Carlo Gambacorti-Passerini, Andrés J.M. Ferreri, Patrizia Tosi, Riccardo Bruna, Mauro Krampera, Antonio Cuneo, Nicola Stefano Fracchiolla, Daniela Cilloni, Lorenza Bertù, Paolo Corradini, Annamaria Scattolin, Roberto Cairoli, Giuseppe Visani, Domenico Penna, Marco Ladetto, Antonello Pinto, Michele Cavo, Monica Bocchia, Sofia Pilerci, Luigi Marcheselli

المساهمون: Visco, C, Marcheselli, L, Mina, R, Sassone, M, Guidetti, A, Penna, D, Cattaneo, C, Bonuomo, V, Busca, A, Ferreri, A, Bruna, R, Petrucci, L, Cairoli, R, Salvini, M, Bertu, L, Ladetto, M, Pilerci, S, Pinto, A, Ramadan, S, Marchesi, F, Cavo, M, Arcaini, L, Coviello, E, Romano, A, Musto, P, Massaia, M, Fracchiolla, N, Marchetti, M, Scattolin, A, Tisi, M, Cuneo, A, Porta, M, Trentin, L, Turrini, M, Gherlinzoni, F, Tafuri, A, Galimberti, S, Bocchia, M, Cardinali, V, Cilloni, D, Corso, A, Armiento, D, Rigacci, L, La Barbera, E, Gambacorti Passerini, C, Visani, G, Vallisa, D, Venditti, A, Selleri, C, Conconi, A, Tosi, P, Lanza, F, Candoni, A, Krampera, M, Corradini, P, Passamonti, F, Merli, F

المصدر: Blood Advances

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c511abaff8f6767b1c8847f0db05744Test
http://hdl.handle.net/11568/1132840Test

9

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

المساهمون: Gay F., Musto P., Rota-Scalabrini D., Bertamini L., Belotti A., Galli M., Offidani M., Zamagni E., Ledda A., Grasso M., Ballanti S., Spadano A., Cea M., Patriarca F., D'Agostino M., Capra A., Giuliani N., de Fabritiis P., Aquino S., Palmas A., Gamberi B., Zambello R., Petrucci M.T., Corradini P., Cavo M., Boccadoro M.

مصطلحات موضوعية: Male, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Combined Modality Therapy, Cyclophosphamide, Dexamethasone, Female, Follow-Up Studies, Hematopoietic Stem Cell Transplantation, Humans, Lenalidomide, Melphalan, Middle Aged, Multiple Myeloma, Oligopeptides, Prognosis, Survival Rate, Thalidomide, Transplantation, Autologous, chemistry.chemical_compound, Maintenance therapy, Monoclonal, Medicine, multiple myeloma, newly diagnosed, carfilzomib, cyclophosphamide, lenalidomide, dexamethasone, induction treatment, autologous stem-cell transplantation, maintenance treatment, phase 2, trial, Multiple myeloma, carfilzomib, trial, induction treatment, Oncology, Oligopeptide, newly diagnosed, Autologous, Human, medicine.drug, medicine.medical_specialty, Prognosi, autologous stem-cell transplantation, Antibodies, Follow-Up Studie, Internal medicine, Autologous transplantation, Transplantation, Antineoplastic Combined Chemotherapy Protocol, maintenance treatment, business.industry, medicine.disease, Settore MED/15, Carfilzomib, chemistry, phase 2, business

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ee9f82acbff156d6f0b7336cbb430aTest
https://hdl.handle.net/2108/318985Test

10

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

المساهمون: Hematology, Ludwig H., Sonneveld P., Facon T., San-Miguel J., Avet-Loiseau H., Mohty M., Mateos M.-V., Moreau P., Cavo M., Pawlyn C., Zweegman S., Engelhardt M., Driessen C., Cook G., Dimopoulos M.A., Gay F., Einsele H., Delforge M., Caers J., Weisel K., Jackson G., Garderet L., van de Donk N., Leleu X., Goldschmidt H., Beksac M., Nijhof I., Schreder M., Abildgaard N., Hajek R., Zojer N., Kastritis E., Broijl A., Schjesvold F., Boccadoro M., Terpos E., Austrian Forum Against Cancer

المصدر: The Lancet Haematology, 8(12), E934-E946. Lancet Publishing Group
Ludwig, H, Sonneveld, P, Facon, T, San-Miguel, J, Avet-Loiseau, H, Mohty, M, Mateos, M V, Moreau, P, Cavo, M, Pawlyn, C, Zweegman, S, Engelhardt, M, Driessen, C, Cook, G, Dimopoulos, M A, Gay, F, Einsele, H, Delforge, M, Caers, J, Weisel, K, Jackson, G, Garderet, L, van de Donk, N, Leleu, X, Goldschmidt, H, Beksac, M, Nijhof, I, Schreder, M, Abildgaard, N, Hajek, R, Zojer, N, Kastritis, E, Broijl, A, Schjesvold, F, Boccadoro, M & Terpos, E 2021, ' COVID-19 vaccination in patients with multiple myeloma : a consensus of the European Myeloma Network ', The Lancet Haematology, vol. 8, no. 12, pp. e934-e946 . https://doi.org/10.1016/S2352-3026Test(21)00278-7
The Lancet. Haematology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d0dabf02ac964a70bc8390dfcafcd3Test
https://pure.eur.nl/en/publications/149fdedf-861b-48b2-aa1a-30968717ac09Test

تنقيح النتائج